BNP Paribas Asset Management Portfolio holdings
AUM
$41B
This Quarter Return
+14.8%
1 Year Return
+19.31%
3 Year Return
+95.01%
5 Year Return
+143.6%
10 Year Return
+355.3%
AUM
$12B
AUM Growth
+$12B
(+10%)
Cap. Flow
-$439M
Cap. Flow
% of AUM
-3.67%
Top 10 Holdings %
Top 10 Hldgs %
16.71%
Holding
962
New
31
Increased
319
Reduced
433
Closed
36
Top Buys
| 1 |
Amazon
AMZN
|
$53.4M |
| 2 |
Home Depot
HD
|
$46.8M |
| 3 |
Trimble
TRMB
|
$33.5M |
| 4 |
Bristol-Myers Squibb
BMY
|
$31.9M |
| 5 |
Cigna
CI
|
$31.1M |
Top Sells
| 1 |
Palo Alto Networks
PANW
|
$41.5M |
| 2 |
Bank OZK
OZK
|
$37.8M |
| 3 |
Zimmer Biomet
ZBH
|
$36.1M |
| 4 |
Estee Lauder
EL
|
$32.3M |
| 5 |
Tyson Foods
TSN
|
$30.2M |
Sector Composition
| 1 | Technology | 17.5% |
| 2 | Consumer Discretionary | 15.17% |
| 3 | Healthcare | 14.96% |
| 4 | Financials | 12.82% |
| 5 | Communication Services | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
IPG Photonics
IPGP
$3.45B
| $70.6M | 0.59% | 465,109 -51,170 | -10% | -$7.77M |
|
27
Vertex Pharmaceuticals
VRTX
$100B
| $68.7M | 0.57% | 373,484 +19,618 | +6% | +$3.61M |
|
28
TSMC
TSM
$1.2T
| $67.7M | 0.57% | 1,652,733 -53,647 | -3% | -$2.2M |
|
29
TJX Companies
TJX
$152B
| $67M | 0.56% | 1,259,247 +33,922 | +3% | +$1.8M |
|
30
Adobe
ADBE
$151B
| $66.3M | 0.55% | 248,611 +21,120 | +9% | +$5.63M |
|
31
JPMorgan Chase
JPM
$829B
| $65.7M | 0.55% | 649,457 -43,634 | -6% | -$4.42M |
|
32
New Oriental
EDU
$7.85B
| $59.8M | 0.5% | 663,330 +69,772 | +12% | +$6.29M |
|
33
Frontdoor
FTDR
$4.43B
| $59.6M | 0.5% | 1,731,095 +358,113 | +26% | +$12.3M |
|
34
Gilead Sciences
GILD
$140B
| $57.8M | 0.48% | 889,510 -26,277 | -3% | -$1.71M |
|
35
Marsh & McLennan
MMC
$101B
| $56.8M | 0.48% | 605,281 -149,216 | -20% | -$14M |
|
36
Hasbro
HAS
$11.4B
| $56.7M | 0.47% | 667,276 +41,878 | +7% | +$3.56M |
|
37
Brunswick
BC
$4.15B
| $56.7M | 0.47% | 1,127,061 -19,685 | -2% | -$991K |
|
38
HDFC Bank
HDB
$182B
| $56.7M | 0.47% | 488,898 +97,939 | +25% | +$11.4M |
|
39
Boston Scientific
BSX
$156B
| $56.5M | 0.47% | 1,473,227 -90,955 | -6% | -$3.49M |
|
40
Medtronic
MDT
$119B
| $55.4M | 0.46% | 608,229 +81,458 | +15% | +$7.42M |
|
|
CELG
41
DELISTED
Celgene Corp
CELG
| $54.9M | 0.46% | 581,753 -112,217 | -16% | -$10.6M |
|
42
Procter & Gamble
PG
$368B
| $54M | 0.45% | 518,505 +86,990 | +20% | +$9.05M |
|
43
Sabre
SABR
$706M
| $53.1M | 0.44% | 2,480,419 +122,172 | +5% | +$2.61M |
|
44
Leggett & Platt
LEG
$1.3B
| $52.5M | 0.44% | 1,244,460 -371,901 | -23% | -$15.7M |
|
|
WUBA
45
DELISTED
58.COM INC
WUBA
| $52.3M | 0.44% | 796,091 -73,310 | -8% | -$4.81M |
|
46
Mondelez International
MDLZ
$79.5B
| $51.9M | 0.43% | 1,038,788 -262,969 | -20% | -$13.1M |
|
47
Amgen
AMGN
$155B
| $51M | 0.43% | 268,399 +148,549 | +124% | +$28.2M |
|
48
Pfizer
PFE
$141B
| $50.4M | 0.42% | 1,185,688 +32,106 | +3% | +$1.36M |
|
|
AGN
49
DELISTED
Allergan plc
AGN
| $50.2M | 0.42% | 342,917 +63,679 | +23% | +$9.32M |
|
50
3M
MMM
$82.8B
| $48.3M | 0.4% | 232,538 -14,007 | -6% | -$2.91M |
|